Dendritic cells produce inflammatory cytokines in response to bacterial products from Staphylococcus aureus-infected atopic dermatitis lesions

Cellular Immunology

Volumn 267, Issue 1, 2011, Pages 17-22

  Voorhees, Timothy ^a   Chang, Jihoon ^a   Yao, Yongxue ^b   Kaplan, Mark H ^b   Chang, Cheong Hee ^a   Travers, Jeffrey B ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atopic dermatitis; Dendritic cells; Interleukin 6; Lipoteichoic acid; Platelet activating factor; Staphylococcus aureus; Tumor necrosis factor

Indexed keywords

BACTERIAL PROTEIN; CALCIUM; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPROTEIN; LIPOTEICHOIC ACID; MYELOID DIFFERENTIATION FACTOR 88; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; ATOPIC DERMATITIS; BACTERIUM CULTURE; CALCIUM CELL LEVEL; CELL ACTIVATION; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; INFLAMMATION; KERATINOCYTE; LIQUID; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; WASH FLUID;

ANIMALS; CYTOKINES; DENDRITIC CELLS; DERMATITIS, ATOPIC; HUMANS; MICE; MICE, INBRED C57BL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); MURINAE; STAPHYLOCOCCUS AUREUS;

EID: 78651076117     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.10.010     Document Type: Article

References (33)

1. Leung D.Y. Infection in atopic dermatitis. Curr. Opin. Pediatr. 2003, 15:399-404.
2. Baker B.S. The role of microorganisms in atopic dermatitis. Clin. Exp. Immunol. 2006, 144:15-43.
3. Sehra S., Barbé Tuana M., Holbreich M., Mousdicas N., Chang C-H., Travers J.B., Kaplan M.H. Scratching the surface. Towards understanding the pathogenesis of atopic dermatitis. Crit. Rev. Immunol. 2008, 28:15-43.
4. Bieber T. Atopic dermatitis. New. Engl. J. Med. 2008, 358:1483-1494.
5. Mandi Y., Endresz V., Krenacs L., Regely K., Degre M., Beladi I. Tumor necrosis factor production by human granulocytes. Int. Arch. Aller. Appl. Immunol. 1991, 96:102-106.
6. Sasaki T., Kano R., Sato H., Nakamura Y., Watanabe S., Hasegawa A. Effects of staphylococci on cytokine production from human keratinocytes. Br. J. Dermatol. 2003, 148:46-50.
7. Michelsen K.S., Aicher A., Mohaupt M., Hartung T., Dimmeler S., Kirschning C.J., Schumann R.R. The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J. Biol. Chem. 2001, 276:25680-25686.
8. Lemjabbar H., Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat. Med. 2002, 8:41-46.
9. Zhang Q., Mousdicas N., Yi Q., Al-Hassani M., Billings S., Perkins S.M., et al. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J. Clin. Invest. 2005, 115:2855-2861.
10. Bell E. Dendritic cells: New DCs found deep in skin. Nat. Rev. Immunol. 2008, 8:2256.
11. Rupec R.A., Boneberger S., Ruzicka T. What is really in control of skin immunity: lymphocytes, dendritic cells, or keratinocytes? Facts and controversies. Clin. Dermatol. 2010, 28:62-66.
12. Novak N., Koch S., Allam J.P., Bieber T. Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis. J. Allerg. Clin. Immunol. 2010, 125:50-59.
13. Travers J.B., Kozman A., Mousdicas N., et al. Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J. Allerg. Clin. Immunol. 2010, 125:146-152.
14. Yao Y., Li W., Kaplan M.H., Chang C.H. Interleukin (IL)-4 inhibits IL-10 to promoted IL-12 production by dendritic cells. J. Exp. Med. 2005, 201:1899-1903.
15. Hanifen J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. 1980, 92:44-47.
16. Hanifin J.M., Thurston M., Omoto M., et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp. Dermatol. 2001, 10:11-18.
17. Williamson P., Kligman A.M. A new method for the quantitative investigation of cutaneous bacteria. J. Invest. Dermat. 1965, 45:498-503.
18. Roses R.E., Xu S., Xu M., Koldovsky U., Koski G., Czerniecki B.J. Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J. Immunol. 2008, 181:5120-5127.
19. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., Liu Y.J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001, 194:863-869.
20. Kim H.J., Yang J.S., Woo S.S., Kim S.K., Yun C.H., Kim K.K., Han S.H. Lipoteichoic acid and muramyl dipeptide synergistically induce maturation of human dendritic cells and concurrent expression of proinflammatory cytokines. J. Leuk. Biol. 2007, 81:983-989.
21. Cardoso L.S., Araujo M.I., Góes A.M., Pacífico L.G., Oliveira R.R., Oliveira S.C. Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microb. Cell Fact. 2007, 6:1.
22. Dichmann S., Rheinen H., Panther E., Herouy Y., Czech W., Termeer C. Et al, Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells. J. Cell. Physiol. 2000, 185:394-400.
23. Sozzani S., Longoni D., Bonecchi R., Luini W., Bersani L., D'Amico G., et al. Human monocyte-derived and CD34+ cell-derived dendritic cells express functional receptors for platelet activating factor. FEBS Lett. 1997, 418:98-100.
24. Au B.T., Williams T.J., Collins P.D. Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator. J. Immunol. 1994, 152:5411-5419.
25. Roth M., Nauck M., Yousefi S., Tamm M., Blaser K., Perruchoud A.P. Et al, Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J. Exp. Med. 1996, 184:191-201.
26. Pei Y., Barber L.A., Murphy R.C., Johnson C.A., Kelley S.W., Dy L.C., et al. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J. Immunol. 1998, 161:1954-1961.
27. Travers J.B., Edenberg H.J., Zhang Q., Al-Hassani M., Yi Q., Baskaran S., et al. Augmentation of UVB radiation-mediated early gene expression by the epidermal platelet-activating factor receptor. J. Invest. Dermatol. 2008, 128:455-460.
28. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 2002, 347:1151-1160.
29. Mrabet-Dahbi S., Dalpke A.H., Markus Frey M.N., Draing C., Brand S., Heeg K., Werfel T., Renz H. The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. Am. Acad. Allerg. Asthma Immunol. 2008, 121:1013-1019.
30. Poehlmann H., Schefold J.C., Zuckermann-Becker H., Volk H.D., Meisel C. Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Cri. Care 2009, 13(4):R119.
31. Keller J.F., Carrouel F., Colomb E., et al. Toll-like receptor 2 activation by lipoteichoic acid induces differential production of pro-inflammatory cytokines in human odontoblasts. Dental pulp fibroblasts and immature dendritic cells. Immunobiology 2010, 215:53-59.
32. Angeli V., Llodra J., Rong J.X., Satoh K., Ishii S., Shimizu T., et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 2004, 21:561-574.
33. Jeong Y.I., Jung I.D., Lee C.M., et al. The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock. PLoS ONE 2009, 4:e6503.